State Street Corp Catalyst Pharmaceuticals, Inc. Transaction History
State Street Corp
- $2.59 Trillion
- Q2 2025
A detailed history of State Street Corp transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, State Street Corp holds 5,478,388 shares of CPRX stock, worth $111 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,478,388
Previous 5,530,437
0.94%
Holding current value
$111 Million
Previous $134 Million
11.36%
% of portfolio
0.0%
Previous 0.01%
Shares
22 transactions
Others Institutions Holding CPRX
# of Institutions
385Shares Held
103MCall Options Held
0Put Options Held
277K-
Black Rock Inc. New York, NY18.7MShares$380 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.77MShares$178 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.25MShares$66.1 Million0.1% of portfolio
-
Morgan Stanley New York, NY3.18MShares$64.8 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.88MShares$58.6 Million1.44% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.09B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...